Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Cornea Specialists (US)

July 18, 2007
Dying PDT
Analysis of: Ranibizumab, PDT combination successfully treats neovascular AMD (www.osnsupersite.com)
Current understanding of AMD recognizes 3 causative factors: angiogenesis, some inflammation and fibrosis. Both  PDT and ranibizumab address the same problem of inhibiting of new vessels growth. Ranibizumab has been shown significantly superior to PDT. Its ability to stop new vessels and reduce...
Analysis of: AMO outbids private equity firm for Bausch & Lomb (www.osnsupersite.com)
In this news release presented today, this leading ophthalmic journal reports that AMO has presented the highest bid for the purchase of Bausch and Lomb.  
Analysis of: Costs of Visual Benefits in Treating Age-Related Macular Degeneration (www.ophsource.org)
Dr Smiddy reviewed age-related macular degeneration studies to evaluate the cost for the visual benefit of various treatment approaches, and then compared them with the costs for treating other retinal conditions. This study founds costs for treating wet macular degeneation could be as high as $9000...
Analysis of: Verteporfin and Intravitreal Bevacizumab Combination Treatment (www.ophsource.org)
In a study of patients with choroidal neovascularization due to age-related macular degeneration, Lazic and Gabric demonstrated that improvements in vision and reduction of central macular thickness after one month and their maintenance over three months are more significant after verteporfin photodynamic...
Analysis of: European Eye Study Links Cigarette Smoking to Age-Related Macular Degeneration (www.ophsource.org)
The European Eye Study (EUREYE) investigated 4,750 randomly sampled people over age 65 and examined the association between cigarette smoking and age-related macular degeneration and concluded that there is a postive correlation to smoking and blindness from macular degeneration.
Analysis of: Femtosecond Laser for Penetrating Keratoplasty (www.ajo.com)
In this latest study with the Intralase femtosecond laser, we see its versatility in being able to produce very efficient and safe corneal cuts for corneal transplant surgery. In addition to producing significant benefits for patients that undergo LASIK, this laser has thereaputic benefits that will...
Analysis of: Intravitreous Dexamethasone Drug Delivery System in Patients With Persistent Macular Edema (archopht.ama-assn.org)
A study reported in the March issue of Archives of Ophthalmology describes a new intravitreous drug delivery system for treating persistent retinal macular swelling. Using dexamethasone DDS and appropriate follow up, patients with this new system had significantly improved vision and and safety mea...
Analysis of: Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage (www.retinajournal.com)
A study by Costa et al. reported in the prestigopis journal RETINA, of seven seven patients with macular SWELLING associated with ischemic retinal vein occlusion treated with intravitreal bevacizumab showed promising short-term results. Patients received two injections of bevacizumab (Avastin)...
Analysis of: Artisan Phakic Intraocular Lens Safe, Effective After 10 Years (www.ophsource.org)
Tahzib et al. conducted a 10-year retrospective follow-up study of the Artisan phakic intraocular lens (PIOL) for the correction of moderate to high nearsigtedness and concluded the device is both stable and predictable, but only when strict inclusion criteria are used. Over 90% of patients achieved...
Analysis of: Novagali Pharma Announces FDA Clearance of IND for US Pivotal Phase III Trial of Nova22007 for Treatment of Dry Eye Syndrome (www.pipelinereview.com)
The current paradigm of Dry Eye disease revolves around inflammation as a key and essential component in its development and progression. Many current and developing regimens (artificial tears, secretagogues such as Ecabet sodium and diquafosol and 15-HETE, mucomimetics such as Milicin, etc...) do...

Previous Page : 1 2 3 4 5 6 Next21 to 30 of 58

Analytics


Generated at 2009-01-08T07:00:19.270